{"resourceId":"embl-alphafold-viral-20260924","versions":[{"version":"external-775c940a26ece947e676b4f1f6ffeb058427c499c3bcc07db14cc37b7a404e79","resource":{"id":"embl-alphafold-viral-20260924","title":"AlphaFold Database adds viral protein complexes for pandemic preparedness (NVIDIA BioNeMo accelerated)","organization":"EMBL / EMBL-EBI","sector":"Life sciences / pandemic preparedness research infrastructure","geography":"International (EMBL-EBI; U.S. SLED research transferable with data-use limits)","publishedAt":"2026-09-24T14:00:24Z","publicationDate":"2026-09-24","eventDate":"2026-09-24","sourceName":"EMBL News","sourceLabel":"Research organization announcement","sourceUrl":"https://www.embl.org/news/science-technology/alphafold-database-adds-viral-protein-complexes-to-support-pandemic-preparedness/","evidenceClass":"independent-research","outcomeClass":"emerging","topics":["developers-agents","infrastructure","data-security"],"finding":"On Sep 24, 2026 EMBL announced that AI-predicted protein complex structures for over 2,800 viruses are openly available in the AlphaFold Database Pandemic Preparedness Portal. Collaborators include Google DeepMind, NVIDIA, Seoul National University, University of Glasgow, SIB, and CEPI. EMBL states predictions used AlphaFold2 with optimisation from NVIDIA BioNeMo Inference Runtime to reach high throughput. This is research infrastructure for epidemic preparedness, not a packaged SLED application.","sledRelevance":"Relevant to university and public-health research computing evaluating BioNeMo/AlphaFold GPU workflows for proteome-scale structure prediction; not a campus chatbot deployment story.","evidence":"EMBL news dated 24 September 2026; names NVIDIA among collaborators; cites BioNeMo Inference Runtime optimisation; states >2,800 viruses openly available in AFDB.","architectureImplications":"GPU-accelerated structure-prediction pipelines become shared research-facility services with large batch inference and AFDB-oriented outputs.","governanceImplications":"Who approves reuse of predicted viral complexes for dual-use review, licensing, and attribution to AFDB/DeepMind/NVIDIA contributors?","securityPrivacyImplications":"Open structural predictions raise dual-use and biosecurity review expectations for labs hosting related inference.","caveats":"Research-org announcement; BioNeMo role is acceleration/optimisation claim, not a measured SLED deployment or clinical outcome.","streamIds":["nvidia"],"roles":{"sales":"Frame this as research-computing infrastructure for pandemic-preparedness structure prediction—not an enterprise chat agent. Open with shared GPU batch inference for AlphaFold-class workloads, then cite EMBL’s Sep 24 release of more than 2,800 viral complexes accelerated with NVIDIA BioNeMo Inference Runtime. Bound the ask to a research-cluster PoC under institutional biosafety review, without claiming clinical readiness or outbreak prevention outcomes. Keep dual-use review on the critical path from first conversation.","engineering":"Fit is strong for research HPC/AI clusters already running structure prediction; weak as a turnkey NIM microservice story from this page alone. Integrate BioNeMo Inference Runtime or an equivalent AlphaFold2 GPU pipeline behind a batch queue and pin versions. Prerequisites: GPU nodes, sequence databases, data licenses. Constraints: proteome-scale jobs dominate GPU-hours; BioNeMo optimisation claims are collaborator-reported. Proof: throughput on a curated viral proteome subset versus baseline.","delivery":"Work includes standing up the prediction pipeline, validating licenses, defining biosafety checkpoints, and publishing access runbooks. Dependencies: storage, scheduler, security review. Ownership: research computing with biosafety co-owner. Skills: GPU ML ops and structural bioinformatics. Governance: dual-use review before external sharing. Acceptance: reproducible predictions for an approved proteome set with audit logs. Risks: dual-use misuse, overstating clinical utility, queue contention. Publish a short dual-use FAQ beside the job-submission guide."},"roleDetails":{"sales":{"customerProblem":"Research groups need open, GPU-scale viral complex structures without rebuilding AlphaFold alone.","stakeholders":["research computing","life-science PIs","biosafety","sponsored research"],"discoveryQuestions":["Which proteome-scale structure jobs are queued today?","Who owns biosafety review for predicted pathogen structures?","Is BioNeMo or AlphaFold already licensed on campus GPUs?"],"valueHypothesis":"Shared BioNeMo-accelerated prediction can expand AFDB-aligned research capacity if governance and GPU queues are explicit.","potentialEngagement":"Scoped PoC: reproduce a small viral proteome batch on campus GPUs with BioNeMo/AlphaFold2 tooling.","unsupportedClaims":["Clinical diagnostic readiness","Guaranteed outbreak prevention","BioNeMo replaces wet-lab validation"]},"engineering":{"fit":"Strong for batch structure-prediction research clusters; weak as a general SLED app platform.","architectureIntegration":"Batch GPU inference service with AFDB-compatible outputs; separate from interactive NIM chat stacks.","prerequisites":["GPU cluster","sequence/MSA inputs","runtime pins","data licenses"],"constraints":["Proteome-scale GPU-hour cost","Collaborator-reported BioNeMo optimisation","Not a clinical device"],"security":"Apply dual-use access controls and audit logging on pathogen-related jobs.","proofOfValue":["Throughput vs baseline on fixed proteome subset","Reproducible structure outputs","License/compliance checklist complete"]},"delivery":{"work":"Deploy prediction pipeline, document access, run approved proteome batch, capture metrics.","dependencies":["Scheduler/queue","Object storage","Biosafety approval","Model/runtime artifacts"],"ownership":"Research computing lead with biosafety co-owner.","skillsAdoption":"Train researchers on job submission and AFDB citation norms.","governanceCheckpoints":["Biosafety review","Data-use approval","External publication review"],"acceptanceCriteria":["Approved proteome batch completes with logged provenance","Outputs match AFDB citation requirements"],"risks":["Dual-use exposure","Queue starvation of other research","Overclaiming clinical impact"]}},"retrievedAt":"2026-09-27T02:58:40Z","enrichedAt":"2026-09-27T03:05:00Z","enrichmentBasis":"retrieved source","accessibilityWorkforceImplications":"Open AFDB access widens researcher participation but still needs GPU-skilled operators for local BioNeMo pipelines.","procurementImplications":"Treat BioNeMo/runtime and GPU capacity as research-facility procurements, not clinical software purchases.","operatingModelImplications":"Central research computing should own pipeline SLOs and biosafety gates rather than each lab reinventing AlphaFold stacks.","sourceVerification":{"openedUrl":"https://www.embl.org/news/science-technology/alphafold-database-adds-viral-protein-complexes-to-support-pandemic-preparedness/","referenceExcerpt":"AI-predicted protein complex structures for over 2,800 viruses are now openly available in the AlphaFold Database","promptVersion":"sled-research-v4.0","model":null,"basis":"agent-reported inspection"}}}]}